These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 14507667)

  • 1. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Ochiai M; Ushigome M; Fujiwara K; Ubagai T; Kawamori T; Sugimura T; Nagao M; Nakagama H
    Am J Pathol; 2003 Oct; 163(4):1607-14. PubMed ID: 14507667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
    Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
    Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
    Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rat colon cancer model induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, PhIP.
    Nakagama H; Ochiai M; Ubagai T; Tajima R; Fujiwara K; Sugimura T; Nagao M
    Mutat Res; 2002 Sep; 506-507():137-44. PubMed ID: 12351153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Matsunaga K; Katayama M; Sakata K; Shimizu M; Kuno T; Mori H
    Cancer Res; 2001 Mar; 61(5):1874-8. PubMed ID: 11280741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess beta-catenin gene mutations and increases immunoreactivity for beta-catenin, cyclooxygenase-2 and inducible nitric oxide synthase.
    Tanaka T; Suzuki R; Kohno H; Sugie S; Takahashi M; Wakabayashi K
    Carcinogenesis; 2005 Jan; 26(1):229-38. PubMed ID: 15459021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More frequent beta-catenin gene mutations in adenomas than in aberrant crypt foci or adenocarcinomas in the large intestines of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-treated rats.
    Tsukamoto T; Tanaka H; Fukami H; Inoue M; Takahashi M; Wakabayashi K; Tatematsu M
    Jpn J Cancer Res; 2000 Aug; 91(8):792-6. PubMed ID: 10965019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent mutation of Apc gene in rat colon tumors and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis.
    Femia AP; Dolara P; Giannini A; Salvadori M; Biggeri A; Caderni G
    Cancer Res; 2007 Jan; 67(2):445-9. PubMed ID: 17234750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation does not precede or accompany the induction of preneoplastic lesions in the colon of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-fed rats.
    Kühnel D; Taugner F; Scholtka B; Steinberg P
    Arch Toxicol; 2009 Aug; 83(8):763-8. PubMed ID: 19212758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and distribution of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced aberrant crypt foci in the rat large intestine.
    Tsukamoto T; Kozaki K; Nishikawa Y; Yamamoto M; Fukami H; Inoue M; Wakabayashi K; Tatematsu M
    Jpn J Cancer Res; 1999 Jul; 90(7):720-5. PubMed ID: 10470283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of aberrant crypt foci by dietary fat and caloric restriction: the effects of delayed intervention.
    Lasko CM; Bird RP
    Cancer Epidemiol Biomarkers Prev; 1995; 4(1):49-55. PubMed ID: 7894324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential staining of dysplastic aberrant crypt foci in the colon facilitates prediction of carcinogenic potentials of chemicals in rats.
    Ochiai M; Watanabe M; Nakanishi M; Taguchi A; Sugimura T; Nakagama H
    Cancer Lett; 2005 Mar; 220(1):67-74. PubMed ID: 15737689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Existence of a threshold for induction of aberrant crypt foci in the rat colon with low doses of 2-amino-1-methyl-6-phenolimidazo[4,5-b]pyridine.
    Fukushima S; Wanibuchi H; Morimura K; Iwai S; Nakae D; Kishida H; Tsuda H; Uehara N; Imaida K; Shirai T; Tatematsu M; Tsukamoto T; Hirose M; Furukawa F
    Toxicol Sci; 2004 Jul; 80(1):109-14. PubMed ID: 15014208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AKT is critically involved in cooperation between obesity and the dietary carcinogen amino-1-methyl-6-phenylimidazo [4,5-b] (PhIP) toward colon carcinogenesis in rats.
    Igarashi M; Hippo Y; Ochiai M; Fukuda H; Nakagama H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):852-7. PubMed ID: 24342614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine induces a higher number of aberrant crypt foci in Fischer 344 (rapid) than in Wistar Kyoto (slow) acetylator inbred rats.
    Purewal M; Velasco M; Fretland AJ; Hein DW; Wargovich MJ
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):529-32. PubMed ID: 10815700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid.
    Magnuson BA; Carr I; Bird RP
    Cancer Res; 1993 Oct; 53(19):4499-504. PubMed ID: 8402621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the malignant potential of aberrant crypt foci by immunohistochemical staining for beta-catenin in inflammation-induced rat colon carcinogenesis.
    Furihata T; Kawamata H; Kubota K; Fujimori T
    Int J Mol Med; 2002 Apr; 9(4):353-8. PubMed ID: 11891526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous development of aberrant crypt foci in F344 rats.
    Furukawa F; Nishikawa A; Kitahori Y; Tanakamaru Z; Hirose M
    J Exp Clin Cancer Res; 2002 Jun; 21(2):197-201. PubMed ID: 12148578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucin-depleted foci have beta-catenin gene mutations, altered expression of its protein, and are dose- and time-dependent in the colon of 1,2-dimethylhydrazine-treated rats.
    Femia AP; Bendinelli B; Giannini A; Salvadori M; Pinzani P; Dolara P; Caderni G
    Int J Cancer; 2005 Aug; 116(1):9-15. PubMed ID: 15751047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.